BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23451618)

  • 1. Scoring life insurance applicants' laboratory results, blood pressure and build to predict all-cause mortality risk.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2012; 43(3):169-77. PubMed ID: 23451618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in mortality of insurance applicants with HIV infection.
    Stout RL; Fulks M; Dolan VF
    J Insur Med; 2012; 43(2):67-75. PubMed ID: 22876410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory and biometric predictors of cancer-related mortality in an insured population.
    Palmier J; Lanzrath BJ
    J Insur Med; 2012; 43(3):162-8. PubMed ID: 23451617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using liver enzymes as screening tests to predict mortality risk.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2008; 40(3-4):191-203. PubMed ID: 19317327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased mortality associated with elevated carcinoembryonic antigen in insurance applicants.
    Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L
    J Insur Med; 2007; 39(4):251-8. PubMed ID: 18522142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum globulin predicts all-cause mortality for life insurance applicants.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2014; 44(2):93-8. PubMed ID: 25816467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-Cause Mortality for Life Insurance Applicants with a Family History of Coronary Artery Disease Before 60.
    Freitas SA; MacKenzie R; Wylde DN; Von Bergen J; Holowaty JC; Beckman M; Rigatti SJ; Gill S
    J Insur Med; 2018 Jan; 47(3):159-171. PubMed ID: 30192720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2014 CRL Build Study of Life Insurance Applicants.
    Fulks M; Dolan VF; Stout RL
    J Insur Med; 2016; 46(1):13-9. PubMed ID: 27562108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin and all-cause mortality risk in insurance applicants.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2010; 42(1):11-7. PubMed ID: 21290995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of vital status ascertainment using the Social Security Death Master File in a deceased population.
    Ashley T; Cheung L; Wokanovicz R
    J Insur Med; 2012; 43(3):135-44. PubMed ID: 23451614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality associated with bilirubin levels in insurance applicants.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2009; 41(1):49-53. PubMed ID: 19518005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine protein/creatinine ratio as a mortality risk predictor in non-diabetics with normal renal function.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2012; 43(2):76-83. PubMed ID: 22876411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-Cause Mortality for Life Insurance Applicants with the Presence of Bundle Branch Block.
    Freitas SA; MacKenzie R; Wylde DN; Von Bergen J; Holowaty JC; Beckman M; Rigatti SJ; Zamarripa D; Gill S
    J Insur Med; 2019; 48(1):36-47. PubMed ID: 31219368
    [No Abstract]   [Full Text] [Related]  

  • 14. All-Cause Mortality for Life Insurance Applicants with a History of Prostate Cancer.
    Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Beckman M; Rigatti SJ; Gill S
    J Insur Med; 2017; 47(2):95-106. PubMed ID: 29490159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-Cause Mortality for Life Insurance Applicants with a History of Breast Cancer.
    Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Hart A; Rigatti SJ; Gill S
    J Insur Med; 2017; 47(1):6-22. PubMed ID: 28836905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between treated hypertension and subsequent mortality in an insured population.
    Ivanovic B; Cumming ME; Pinkham CA
    J Insur Med; 2004; 36(1):16-26. PubMed ID: 15104026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of policies on insured lives with elevated blood pressure known at time of issue.
    Woodman H; Mast J; Milano A; Ingle D; Bergstrom R; Hart A; Hoffman NJ
    J Insur Med; 2003; 35(2):72-84. PubMed ID: 14733030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Questionnaire based mortality assessment: an exploratory analysis of NHANES III.
    Bloom T; Krause KJ
    J Insur Med; 2012; 43(1):10-7. PubMed ID: 22397126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age dependent decline of relative risks in life insurance medical underwriting.
    Kneepkens RF; Lindeboom R
    J Insur Med; 2014; 44(3):170-83. PubMed ID: 25622389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline distribution and correlation analysis of hsCRP in an insurance applicant population.
    Krause KJ; Williams DS; White N
    J Insur Med; 2008; 40(2):124-9. PubMed ID: 19119592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.